Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 68788-7601

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68788-7601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 01

Chemical structure of tramadol hydrochloride showing its molecular framework including aromatic ring, hydroxyl group, and dimethylamino substituent, associated with the hydrochloride salt.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 02

A line graph comparing tramadol concentration (ng/mL) over 24 hours for two formulations: Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily, and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time in hours, and the y-axis shows tramadol concentration in ng/mL, illustrating the pharmacokinetic profiles of each dosage form.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 03

A line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily, and Tramadol Hydrochloride Tablets, 50 mg every 6 hours. The y-axis shows M1 concentration from 0 to 120 ng/mL, and the x-axis shows time in hours from 0 to 24.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 04

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis.' It depicts the percent of patients achieving various levels of response threshold (percent improvement from baseline) on the X-axis and percent of patients achieving response on the Y-axis. The graph compares Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg, and a Placebo group, showing response trends across these groups with different symbol markings for each dose and placebo.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 05

A line graph depicting the percent of patients achieving various levels of response threshold in an arthritis pain intensity study comparing Tramadol Hydrochloride extended-release tablets to placebo. The x-axis represents response threshold as percent improvement from baseline (0% to 100%), and the y-axis shows percent of patients achieving response. Two lines with markers compare Tramadol Hydrochloride extended-release tablets and placebo.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 07

Label for Tramadol Hydrochloride ER Tablets 200mg extended-release oral tablets by Preferred Pharmaceuticals, Inc. The label states it is generic for Ultram ER, includes dosage form and strength, and storage instructions. It shows tablet count and batch space fields, dosing directions in English and Spanish, a barcode, and manufacturer information Lupin Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.